E. Kovats

713 total citations
23 papers, 569 citations indexed

About

E. Kovats is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. Kovats has authored 23 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. Kovats's work include Colorectal Cancer Treatments and Studies (7 papers), Colorectal Cancer Surgical Treatments (6 papers) and Colorectal and Anal Carcinomas (6 papers). E. Kovats is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Colorectal Cancer Surgical Treatments (6 papers) and Colorectal and Anal Carcinomas (6 papers). E. Kovats collaborates with scholars based in Austria, Germany and Hungary. E. Kovats's co-authors include Werner Scheithauer, D. Depisch, Gabriela Kornek, Fritz Lang, Markus Raderer, Bruno Schneeweiß, B. Schüll, Katharina Schmid, A. Lenauer and W. Kwasny and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and The Journal of Organic Chemistry.

In The Last Decade

E. Kovats

23 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Kovats Austria 12 408 161 119 85 79 23 569
J. Vignoud France 9 693 1.7× 168 1.0× 220 1.8× 27 0.3× 168 2.1× 14 857
Giuseppe Pezzella Italy 10 667 1.6× 153 1.0× 290 2.4× 82 1.0× 231 2.9× 11 818
Robert S. de Jong Netherlands 13 607 1.5× 119 0.7× 232 1.9× 71 0.8× 159 2.0× 21 838
L Rausa Italy 12 261 0.6× 66 0.4× 80 0.7× 88 1.0× 20 0.3× 80 569
F. Bertheault-Cvitkovic France 11 852 2.1× 258 1.6× 254 2.1× 80 0.9× 405 5.1× 15 1.0k
J Llory France 2 1.0k 2.5× 258 1.6× 268 2.3× 73 0.9× 360 4.6× 2 1.2k
A. Le Rol France 2 924 2.3× 238 1.5× 254 2.1× 73 0.9× 319 4.0× 2 1.1k
Suzanne M. Fields United States 12 385 0.9× 111 0.7× 143 1.2× 49 0.6× 14 0.2× 15 610
Gianfranco Porcile Italy 8 848 2.1× 214 1.3× 321 2.7× 85 1.0× 421 5.3× 18 1.0k
C. Louvet France 12 541 1.3× 124 0.8× 207 1.7× 72 0.8× 101 1.3× 46 648

Countries citing papers authored by E. Kovats

Since Specialization
Citations

This map shows the geographic impact of E. Kovats's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Kovats with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Kovats more than expected).

Fields of papers citing papers by E. Kovats

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Kovats. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Kovats. The network helps show where E. Kovats may publish in the future.

Co-authorship network of co-authors of E. Kovats

This figure shows the co-authorship network connecting the top 25 collaborators of E. Kovats. A scholar is included among the top collaborators of E. Kovats based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Kovats. E. Kovats is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scheithauer, Werner, Gabriela Kornek, Stefan Brugger, et al.. (2002). Randomized Phase II Study of Irinotecan Plus Mitomycin C vs. Oxaliplatin Plus Mitomycin C in Patients with Advanced Fluoropyrimidine/Leucovorin-Pretreated Colorectal Cancer. Cancer Investigation. 20(1). 60–68. 24 indexed citations
2.
Kornek, Gabriela, K. Haider, W. Kwasny, et al.. (2002). Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.. PubMed. 8(5). 1051–6. 40 indexed citations
3.
Kornek, Gabriela, H. Ulrich-Pur, K. Haider, et al.. (2001). Treatment of Advanced Breast Cancer with Vinorelbine and Docetaxel With or Without Human Granulocyte Colony-Stimulating Factor. Journal of Clinical Oncology. 19(3). 621–627. 36 indexed citations
4.
Scheithauer, Werner, Gabriela Kornek, Markus Raderer, et al.. (1999). Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma. British Journal of Cancer. 80(11). 1797–1802. 39 indexed citations
5.
Haider, K., Gabriela Kornek, W. Kwasny, et al.. (1999). Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony‐stimulating factor. Breast Cancer Research and Treatment. 55(3). 203–211. 39 indexed citations
6.
Ulrich-Pur, H., S. Brugger, Wolfgang Fiebiger, et al.. (1999). Randomized phase II study of CPT-11 plus mitomycin C versus oxaliplatin plus mitomycin C in previously treated patients with advanced colorectal cancer (ACC). European Journal of Cancer. 35. S72–S73. 2 indexed citations
7.
Scheithauer, Werner, A Marczell, J. Karner, et al.. (1998). Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. British Journal of Cancer. 77(8). 1349–1354. 72 indexed citations
8.
Scheithauer, Werner, A Marczell, J. Karner, et al.. (1997). Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study.. Journal of Clinical Oncology. 15(3). 908–914. 27 indexed citations
9.
Rogy, Michael A., et al.. (1993). CCK-8 and gastrin plasma levels in cholecystectomized and colorectal cancer patients. International Journal of Colorectal Disease. 8(3). 154–157. 1 indexed citations
10.
Rogy, Michael A., et al.. (1990). Pneumatosis cystoides intestinalis (PCI). International Journal of Colorectal Disease. 5(2). 120–124. 22 indexed citations
11.
Feil, W., M Wunderlich, E. Kovats, et al.. (1988). Rectal cancer: factors influencing the development of local recurrence after radical anterior resection. International Journal of Colorectal Disease. 3(4). 195–200. 25 indexed citations
12.
Wunderlich, M, R Schiessel, H. Rainer, et al.. (1985). Effect of adjuvant chemo- or immunotherapy on the prognosis of colorectal cancer operated for cure. British journal of surgery. 72(Supplement_1). s107–s110. 14 indexed citations
13.
Contreras, F, P. Polterauer, G. Kretschmer, et al.. (1984). Postoperative assessment of below-knee bypass grafts.. PubMed. 158(4). 339–43. 4 indexed citations
14.
Lechner, G., et al.. (1984). Lateral distant view for improved accuracy in locating rectal tumors. American Journal of Roentgenology. 142(3). 519–523. 8 indexed citations
15.
Schiessel, R, et al.. (1983). [Therapy of local recurrence after colorectal cancer].. PubMed. 95(9). 295–7. 3 indexed citations
16.
Schiessel, R, et al.. (1983). [Sphincter preservation in rectal cancer: possibilities and limits of anterior resection].. PubMed. 95(21). 769–73. 3 indexed citations
18.
Buechi, George, et al.. (1968). Synthesis of rosefuran and dehydroelsholtzione. The Journal of Organic Chemistry. 33(3). 1227–1229. 49 indexed citations
19.
Szabó, Zoltán & E. Kovats. (1965). [SUICIDE ATTEMPT WITH 1000 UNITS OF PROTAMINE ZINC INSULIN].. PubMed. 24. 160–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026